These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25526079)

  • 1. Exploring the binding mechanisms of MIF to CXCR2 using theoretical approaches.
    Xu L; Li Y; Li D; Xu P; Tian S; Sun H; Liu H; Hou T
    Phys Chem Chem Phys; 2015 Feb; 17(5):3370-82. PubMed ID: 25526079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment.
    Weber C; Kraemer S; Drechsler M; Lue H; Koenen RR; Kapurniotu A; Zernecke A; Bernhagen J
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16278-83. PubMed ID: 18852457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism.
    Kraemer S; Lue H; Zernecke A; Kapurniotu A; Andreetto E; Frank R; Lennartz B; Weber C; Bernhagen J
    FASEB J; 2011 Mar; 25(3):894-906. PubMed ID: 21106938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4.
    Lacy M; Kontos C; Brandhofer M; Hille K; Gröning S; Sinitski D; Bourilhon P; Rosenberg E; Krammer C; Thavayogarajah T; Pantouris G; Bakou M; Weber C; Lolis E; Bernhagen J; Kapurniotu A
    Sci Rep; 2018 Mar; 8(1):5171. PubMed ID: 29581527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding microscopic binding of macrophage migration inhibitory factor with phenolic hydrazones by molecular docking, molecular dynamics simulations and free energy calculations.
    Xu L; Li Y; Li L; Zhou S; Hou T
    Mol Biosyst; 2012 Sep; 8(9):2260-73. PubMed ID: 22739754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion.
    Liehn EA; Kanzler I; Konschalla S; Kroh A; Simsekyilmaz S; Sönmez TT; Bucala R; Bernhagen J; Weber C
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2180-6. PubMed ID: 23868943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
    Zhang H; Ye YL; Li MX; Ye SB; Huang WR; Cai TT; He J; Peng JY; Duan TH; Cui J; Zhang XS; Zhou FJ; Wang RF; Li J
    Oncogene; 2017 Apr; 36(15):2095-2104. PubMed ID: 27721403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE.
    Rajasekaran D; Gröning S; Schmitz C; Zierow S; Drucker N; Bakou M; Kohl K; Mertens A; Lue H; Weber C; Xiao A; Luker G; Kapurniotu A; Lolis E; Bernhagen J
    J Biol Chem; 2016 Jul; 291(30):15881-95. PubMed ID: 27226569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.
    Xu L; Li Y; Sun H; Li D; Hou T
    Mol Biosyst; 2013 Aug; 9(8):2107-17. PubMed ID: 23702796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.
    Lo MC; Yip TC; Ngan KC; Cheng WW; Law CK; Chan PS; Chan KC; Wong CK; Wong RN; Lo KW; Ng WT; Lee WM; Tsao SW; Kwong LW; Lung ML; Mak NK
    Cancer Lett; 2013 Jul; 335(1):81-92. PubMed ID: 23403077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation.
    Brandhofer M; Hoffmann A; Blanchet X; Siminkovitch E; Rohlfing AK; El Bounkari O; Nestele JA; Bild A; Kontos C; Hille K; Rohde V; Fröhlich A; Golemi J; Gokce O; Krammer C; Scheiermann P; Tsilimparis N; Sachs N; Kempf WE; Maegdefessel L; Otabil MK; Megens RTA; Ippel H; Koenen RR; Luo J; Engelmann B; Mayo KH; Gawaz M; Kapurniotu A; Weber C; von Hundelshausen P; Bernhagen J
    Cell Mol Life Sci; 2022 Sep; 79(10):512. PubMed ID: 36094626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
    Bernhagen J; Krohn R; Lue H; Gregory JL; Zernecke A; Koenen RR; Dewor M; Georgiev I; Schober A; Leng L; Kooistra T; Fingerle-Rowson G; Ghezzi P; Kleemann R; McColl SR; Bucala R; Hickey MJ; Weber C
    Nat Med; 2007 May; 13(5):587-96. PubMed ID: 17435771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-γ-mediated skin inflammation.
    Hsieh CY; Chen CL; Lin YS; Yeh TM; Tsai TT; Hong MY; Lin CF
    J Immunol; 2014 Oct; 193(7):3693-703. PubMed ID: 25172501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of PDZ-mediated chemokine receptor CXCR2 scaffolding by guanine nucleotide exchange factor PDZ-RhoGEF.
    Spellmon N; Holcomb J; Niu A; Choudhary V; Sun X; Zhang Y; Wan J; Doughan M; Hayden S; Hachem F; Brunzelle J; Li C; Yang Z
    Biochem Biophys Res Commun; 2017 Apr; 485(2):529-534. PubMed ID: 28179147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free energy calculations of the interactions of c-Jun-based synthetic peptides with the c-Fos protein.
    Zuo Z; Gandhi NS; Arndt KM; Mancera RL
    Biopolymers; 2012 Nov; 97(11):899-909. PubMed ID: 22899365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
    Spencer ES; Dale EJ; Gommans AL; Rutledge MT; Vo CT; Nakatani Y; Gamble AB; Smith RA; Wilbanks SM; Hampton MB; Tyndall JD
    Eur J Med Chem; 2015 Mar; 93():501-10. PubMed ID: 25743213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIF intersubunit disulfide mutant antagonist supports activation of CD74 by endogenous MIF trimer at physiologic concentrations.
    Fan C; Rajasekaran D; Syed MA; Leng L; Loria JP; Bhandari V; Bucala R; Lolis EJ
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):10994-9. PubMed ID: 23776208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.
    Bendrat K; Al-Abed Y; Callaway DJ; Peng T; Calandra T; Metz CN; Bucala R
    Biochemistry; 1997 Dec; 36(49):15356-62. PubMed ID: 9398265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
    DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC
    Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.
    Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM
    Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.